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The two most common inherited forms of colorectal cancer
are familial adenomatous polyposis and hereditary
non-polyposis colorectal cancer. Simultaneous inheritance
of both an APC gene mutation and a mismatch repair gene
(for example, MLH1) mutation has never been described.
In the present case report, we report rapidly progressive
adenomatous polyposis in a 10 year old boy with a germ-
line frame shift mutation in the APC gene and a germline
splice site mutation in the MLH1 gene. Immunohisto-
chemical investigations showed abnormal expression of
β-catenin in early adenomas with low grade dysplasia,
attributed to the APC gene mutation. Subsequent loss of
function of the MLH1 gene, as shown by absent immuno-
staining of its protein in adenomas with high grade
dysplasia, may well have caused the rapid progression to
high grade dysplasia in many of the adenomas.
The two most common inherited conditions predisposingto colorectal cancer are familial adenomatous polyposis(FAP), caused by germline mutations in the APC (adeno-
matous polyposis coli) tumour suppressor gene, and heredi-
tary non-polyposis colorectal cancer (HNPCC), caused by
germline mutations in one of the DNA mismatch repair
(MMR) genes. Together, FAP and HNPCC account for approxi-
mately 2% of colorectal cancer cases.1 2 In this report, a case is
presented of a patient manifesting a severe phenotype who
had inherited germline mutations in both the APC gene and
the MMR gene MLH1.
CASE REPORT
A 10 year old boy attended the outpatient clinic for evaluation
of slimy and bloody stools. His mother had previously been
diagnosed with FAP. At the age of 27 years, she underwent
prophylactic colectomy. Due to the development of extensive
abdominal fibromatosis (desmoid tumour), she died at the age
of 32 years. Genetic analysis had revealed a germline de novo
frame shift mutation in exon 15 of the APC gene (a 5 bp dele-
tion at codon 1309). The father of the boy is healthy but has a
classical family history of HNPCC and carries a germline splice
site mutation in theMLH1 gene (codon 226, G to A at position
677).
Physical examination was unremarkable. Colonoscopy
revealed hundreds of polyps throughout the colon. Some were
removed and histopathological examination showed small
tubular adenomas with low grade dysplasia. Six months later
endoscopic and histopathological examinations were re-
peated, again showing multiple tubular adenomas, this time
with high grade dysplasia (see fig 1). Subsequently, the boy
underwent proctocolectomy with ileal pouch-anal anastomo-
sis. The surgical specimen showed a large number of
adenomas of which many contained areas with high grade
dysplasia. Genetic analysis revealed that the patient had
inherited both his mother’s APC gene mutation as well as his
father’s MLH1 gene defect.
DISCUSSION
FAP is characterised by the development of multiple colorectal
adenomas at a young age, usually before 20 years. Left
untreated, one or more of the adenomas will have progressed
to cancer before the age of 45 years. Therefore, most patients
have a prophylactic colectomy in the second or third decade of
life. The APC protein, dysfunctional in FAP, regulates the
intracellular level of β-catenin, and controls diverse physio-
logical processes in the colon epithelium including cell
growth, adhesion, and apoptosis.3
HNPCC is caused by germline mutations in one of the DNA
MMR genes, including MLH1, MSH2, and MSH6.4 MMR
deficient cells rapidly accumulate somatic mutations thus
explaining the accelerated tumour progression in HNPCC
patients.4 Clinical features of HNPCC include colorectal cancer
at an early age (mean 45 years) with a predilection for the
proximal colon, an increased frequency of poorly differenti-
ated mucinous tumours, and a high incidence of extracolonic
tumours (for example, endometrium, ovary, urinary tract).
To the best of our knowledge, simultaneous inheritance of
both types of gene defects in one patient has not been reported
previously. The 5 bp deletion at codon 1309 of the APC gene is
the most commonly reported change in FAP patients and is
typically associated with a severe phenotype with an early
onset of disease and the presence of extensive polyposis.5 The
MLH1mutation we found has previously been described and is
not associated with a particular phenotype.6
In our patient, the germline APC mutation, followed by
somatic loss of the wild-type allele, is likely to have triggered
early and multiple adenoma formation. This is illustrated by
abnormal expression of β-catenin that was seen in the early
adenomas (fig 1). Loss of MMR function, due to the germline
MLH1 mutation, and loss of the wild-type allele, may well
underlie the rapid progression of dysplasia in our patient. The
relevance of MMR dysfunction is supported by the finding
that progression from low to high grade dysplasia observed in
the adenomas was associated with loss of MLH1 expression
(fig 1).
In addition, evidence has emerged from several animal
studies of the important role of MMR genes in accelerated
intestinal tumorigenesis, especially in an APC deficient
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background.7 8 In mice carrying both APC and MLH1
mutations, the incidence of intestinal adenomas was mark-
edly increased compared with mice carrying only one of these
mutations.7 8 Alternatively, the severe phenotype in our patient
may in fact reflect the marked heterogeneity which is known
to exist in both FAP and HNPCC.9 10
Our patient probably has a higher risk of developing cancer
at other sites than average FAP or HNPCC mutation carriers.
Intensive follow up and surveillance are therefore warranted.
In conclusion, our case represents the first report of a
patient with adenomatous polyposis who carried both a
pathogenic APC and MLH1 germline mutation. The early
adenoma onset and the rapid tumour progression in this
patient illustrate that the multistep process of colorectal
carcinogenesis in this setting was markedly accelerated.
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Figure 1 Normal colonic mucosa and areas of adenomatous epithelium with low grade dysplasia (A-C) and adenomatous epithelium with
high grade dysplasia (D-F). Serial haematoxylin-eosin staining (A, D) and immunohistochemical (brown) staining of β-catenin (B, E) and MLH1
protein (C, F). In the adenomatous areas with low grade dysplasia, β- catenin staining is normal (membranous) in normal mucosa, in contrast
with abnormal (cytoplasmic and nuclear) staining in adenomatous areas; MLH1 protein is expressed in both normal mucosa and adenomatous
epithelium. In the adenomatous epithelium with high grade dysplasia, β-catenin staining is similar to the adenomatous areas with low grade
dysplasia, whereas MLH1 protein expression is seen in normal mucosa but lost in areas with high grade dysplasia (magnification 100×).
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